LENZ Therapeutics (LENZ) Earnings Date & Reports

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LENZ is expected to report earnings to fall 2.93% to -99 cents per share on November 11

LENZ Therapeutics LENZ Stock Earnings Reports

Q3'26

Est.

$-0.99

Q2'26

Beat

by $0.05

Q1'26

Missed

by $0.15

Q4'25

Missed

by $0.40

Q3'25

Missed

by $0.19

The last earnings report on August 11 showed earnings per share of -101 cents, beating the estimate of -107 cents. With 544.40K shares outstanding, the current market capitalization sits at 118.14M.

View a ticker or compare two or three

LENZ

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for LENZ